CVS Health dividend and valuation

CVS · NYSE · USD

Compare CVS Health
$85.81Change from previous close: −3.14%Absolute change: −$2.78

Close · November 17, 2026

Valuation

CVS Health paid $2.66 per share in dividends over the last 12 months (yield 3.1%). Last ex-dividend date: October 22, 2026. The P/E ratio is 10.4. The average price target of 26 analysts is $109.31.

Data as of November 17, 2026

CVS Health compared with similar companies

CVS Health's P/E (trailing 12 months): 10.4, −45% against the median of a group of 7 similar companies (18.9).

CVS Health's metrics compared with similar companies
MetricCVS HealthMedian25th–75th percentileBand
P/E (trailing 12 months)10.418.911.9 – 23.2Low
Forward P/E10.214.39.81 – 16.2Middle
EV/EBITDA10.19.858.65 – 12.3Middle
Price/book1.412.151.69 – 2.42Low
Price/sales0.270.320.28 – 0.65Low
Gross margin13.7%13.7%12.5% – 22.5%Middle
Operating margin3.1%3.9%2.7% – 4.9%Middle
Net margin2.6%2.5%1.6% – 3.1%Middle
ROE14.4%14.4%9.2% – 16.3%Middle
Debt/equity0.930.700.69 – 0.75High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

CVS Health: valuation over time

On the latest fiscal year's earnings (2025), CVS Health's P/E today is 62.1, above the median of its last 9 fiscal years (14.6; between 11.3 and 57.1 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (3.1%) is in line with the median of the last 10 fiscal years (2.8%).

CVS Health P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025$79.36$1.3957.1$2.663.4%
2024$44.89$3.6612.3$2.665.9%
2023$78.96$6.4712.2$2.423.1%
2022$93.19$3.2628.6$2.202.4%
2021$103.16$6.0217.1$2.001.9%
2020$68.30$5.4612.5$2.002.9%
2019$74.29$5.0814.6$2.002.7%
2018$65.52-$0.57—$2.003.1%
2017$72.50$6.4411.3$2.002.8%
2016$78.91$4.9016.1$1.702.2%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$113.35B
Enterprise value
$173.95B
PEG
0.22
EV/revenue
0.42

Profitability and growth

ROA
3.1%
Revenue growth (year over year)
5.4%

Financial health

Total cash
$14.89B
Total debt
$75.3B
Current ratio
0.85
Quick ratio
0.61

Dividends

Annual dividend per share
$2.66
Dividend yield
3.1%
Payout ratio
31.1%
Ex-dividend date
October 22, 2026

Analysts and estimates

Average price target
$109.31
Median price target
$109.00
High price target
$146.00
Low price target
$86.00
Analysts with a price target
26
Consensus
Strong buy
Forward EPS
$8.70
EPS estimate, current year
$8.28

Shares and trading

Beta
0.58
Average volume
8.95M
Shares outstanding
1.28B
Float
1.28B
Institutional ownership
90.4%
Insider ownership
0.3%
Short interest (% of float)
1.4%
Short ratio (days)
2.13